research use only

Divarasib (GDC-6036) KRAS G12C Inhibitor

Cat.No.E1187

Divarasib (GDC-6036, RG6330) is a KRAS G12C inhibitor that binds irreversibly to switch II pocket of KRAS G12C (when in the inactive GDP-bound state) thereby blocking GTP binding and activation.
Jump to

Quality Control

Batch: E118701 DMSO]100 mg/mL]false]Ethanol]100 mg/mL]false]Water]Insoluble]false Purity: 99.62%
99.62

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (160.75 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 622.06 Formula

C29H32ClF4N7O2

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 2417987-45-0 -- Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

Targets/IC50/Ki
KRAS G12C
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-09-02)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05862285 RECRUITING
Cancer
Hoffmann-La Roche
2023-06-01 PHASE3
NCT04589845 ACTIVE_NOT_RECRUITING
Solid Tumors
Hoffmann-La Roche
2021-01-18 PHASE2
NCT07541170 RECRUITING
Non-small Cell Lung Cancer
Hoffmann-La Roche
2026-09-01 PHASE3
NCT05789082 RECRUITING
Non-Small Cell Lung Cancer
Hoffmann-La Roche
2023-06-20 PHASE1; PHASE2
NCT04929223 RECRUITING
Metastatic Colorectal Cancer
Hoffmann-La Roche
2021-10-22 PHASE1
NCT06793215 RECRUITING
Non-Small Cell Lung Cancer; KRAS G12C Lung Cancer
Hoffmann-La Roche
2025-10-24 PHASE3

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map